{"filing":{"accession_number":"0001193125-26-248640","cik":"0001498382","ticker":"HURA","company_name":"TuHURA Biosciences, Inc./NV","form":"8-K","filing_date":"2026-05-29","report_date":null,"primary_document":"hura-20260526.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1498382/000119312526248640/hura-20260526.htm"},"events":[{"id":8137,"run_id":7143,"accession_number":"0001193125-26-248640","anchor_item_number":"2.03","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.65,"summary":"The filing discloses a draw of $1.7 million under a $50 million revolving credit facility established on April 21, 2026 with Parkview Holdings One LLC. While Item 2.03 is the appropriate disclosure vehicle for creation of direct financial obligations, this particular event—the first draw under a previously disclosed credit facility—is a routine drawdown rather than a material new obligation event. The material event (the Loan Agreement itself) was disclosed on April 22, 2026; this May 26 draw is administrative follow-through. However, marked material=true because the $50 million facility and its use for general corporate purposes could be significant to investor assessment of the company's liquidity and capital structure.","company_name":"TuHURA Biosciences, Inc./NV","ticker":"HURA","filing_date":"2026-05-29","form":"8-K","submitted_at":null,"items":[{"id":2739,"accession_number":"0001193125-26-248640","item_number":"2.03","item_title":"Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.65,"reasoning":"The filing discloses a draw of $1.7 million under a $50 million revolving credit facility established on April 21, 2026 with Parkview Holdings One LLC. While Item 2.03 is the appropriate disclosure vehicle for creation of direct financial obligations, this particular event—the first draw under a previously disclosed credit facility—is a routine drawdown rather than a material new obligation event. The material event (the Loan Agreement itself) was disclosed on April 22, 2026; this May 26 draw is administrative follow-through. However, marked material=true because the $50 million facility and its use for general corporate purposes could be significant to investor assessment of the company's liquidity and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-30T02:15:19.725673+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":2739,"accession_number":"0001193125-26-248640","item_number":"2.03","item_title":"Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.65,"reasoning":"The filing discloses a draw of $1.7 million under a $50 million revolving credit facility established on April 21, 2026 with Parkview Holdings One LLC. While Item 2.03 is the appropriate disclosure vehicle for creation of direct financial obligations, this particular event—the first draw under a previously disclosed credit facility—is a routine drawdown rather than a material new obligation event. The material event (the Loan Agreement itself) was disclosed on April 22, 2026; this May 26 draw is administrative follow-through. However, marked material=true because the $50 million facility and its use for general corporate purposes could be significant to investor assessment of the company's liquidity and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-30T02:15:19.725673+00:00","company_name":"TuHURA Biosciences, Inc./NV","ticker":"HURA","filing_date":"2026-05-29"}]}